SCHEMBL29919151

SCHEMBL29919151

CC(=O)SCc1cncs1

nearest known ligand 0.39

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 3/20 0.39
NPC1 O15118 2/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
CYP2E1 P05181 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2D6 P10635 1/20 0.39
CYP2A6 P11509 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2B6 P20813 1/20 0.39
CYP2C19 P33261 1/20 0.39
PARP15 Q460N3 1/20 0.39
PARP10 Q53GL7 1/20 0.39
TDP1 Q9NUW8 1/20 0.38
SLC6A3 Q01959 8/20 0.36
LMNA P02545 2/20 0.36
TRPM8 Q7Z2W7 1/20 0.35
HTT P42858 2/20 0.34
ACACB O00763 1/20 0.34
SLC6A2 P23975 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16892250 0.75
SCHEMBL273463 0.74
SCHEMBL10681570 0.70 CYP2E1 (0.36) CYP2E1CYP3A4CYP2D6CYP2A6CYP2C9
SCHEMBL14189540 0.69 RAB9A (0.41) RAB9ANPC1SMN1; SMN2CYP3A4PARP15
SCHEMBL31206750 0.69 HCAR2 (0.43) RAB9ANPC1SMN1; SMN2CYP2E1CYP3A4
SCHEMBL16887640 0.68 RAB9A (0.40) RAB9ANPC1SMN1; SMN2PARP15PARP10
SCHEMBL2149970 0.68 CYP2C19 (0.47) RAB9ANPC1SMN1; SMN2CYP2C19TDP1
SCHEMBL19475116 0.67 RAB9A (0.40) RAB9ANPC1SMN1; SMN2PARP15PARP10
SCHEMBL16886384 0.67 RAB9A (0.39) RAB9ANPC1SMN1; SMN2PARP15PARP10
SCHEMBL9481 0.66 CTSK (0.43) RAB9ANPC1SMN1; SMN2PARP15PARP10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12612374-B2 Thiazole and diphenyl substituted sulfoxides for use in improving cognition functions and against addictions to substances COGMOTIV FLEXCO (AT) 2026-04-28 US disclosed
US-20220324821-A1 THIAZOLE AND DIPHENYL SUBSTITUTED SULFOXIDES FOR USE IN IMPROVING COGNITION FUNCTIONS AND AGAINST ADDICTIONS TO SUBSTANCES COGMOTIV FLEXCO (AT) 2022-10-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12612374-B2 Thiazole and diphenyl substituted sulfoxides for use in improving cognition functions and against addictions to substances CHAT, PNMT, CHRM5 RAB9A 2560/4885NPC1 3084/4885SMN1; SMN2 483/4885
US-20220324821-A1 THIAZOLE AND DIPHENYL SUBSTITUTED SULFOXIDES FOR USE IN IMPROVING COGNITION FUNCTIONS AND AGAINST ADDICTIONS TO SUBSTANCES COMT, TST, PNMT RAB9A 1634/4885NPC1 1758/4885SMN1; SMN2 1629/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.